Claims for Patent: 10,463,673

Summary for Patent: 10,463,673

Title:	Nanoparticulate meloxicam formulations
Abstract:	The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Inventor(s):	Cooper; Eugene R. (Berwyn, PA), Ryde; Tuula (Malvern, PA), Pruitt; John (Suwanee, GA), Kline; Laura (Harleysville, PA)
Assignee:	Recro Pharma, Inc. (Malvern, PA)
Application Number:	15/950,367
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,463,673
Patent Claims:	1. An injectable pharmaceutical dosage form consisting of: 30 mg of meloxicam, or a salt thereof, wherein the meloxicam is in the form of particles having an effective average particle size of less than about 200 nm; polyvinylpyrrolidone; sodium deoxycholate; sucrose; and water. 2. The dosage form of claim 1, wherein the effective average particle size of the meloxicam particles, or a salt thereof, is less than about 150 nm. 3. The dosage form of claim 1, wherein the effective average particle size of the meloxicam particles, or a salt thereof, is less than about 100 nm. 4. A method of administering meloxicam to a human in need thereof comprising intravenously or intramuscularly injecting the pharmaceutical dosage form of claim 1 into the human.